In last trading session, Icecure Medical Ltd (NASDAQ:ICCM) saw 0.45 million shares changing hands with its beta currently measuring 0. Company’s recent per share price level of $1.41 trading at -$0.09 or -6.00% at ring of the bell on the day assigns it a market valuation of $79.76M. That closing price of ICCM’s stock is at a discount of -17.73% from its 52-week high price of $1.66 and is indicating a premium of 65.96% from its 52-week low price of $0.48.
For Icecure Medical Ltd (ICCM), analysts’ consensus is at an average recommendation of Buy while assigning it a mean rating of 1.00. Splitting up the data highlights that, out of 1 analysts covering the stock, 0 rated the stock as a Sell while 0 recommended an Overweight rating for the stock. 0 suggested the stock as a Hold whereas 1 see the stock as a Buy. 0 analyst(s) advised it as an Underweight.
Icecure Medical Ltd (NASDAQ:ICCM) trade information
Upright in the red during last session for losing -6.00%, in the last five days ICCM remained trading in the green while hitting it’s week-highest on Wednesday, 02/19/25 when the stock touched $1.41 price level, adding 15.06% to its value on the day. Icecure Medical Ltd’s shares saw a change of 28.18% in year-to-date performance and have moved 2.92% in past 5-day. Icecure Medical Ltd (NASDAQ:ICCM) showed a performance of 19.49% in past 30-days.
Wall Street analysts have assigned a consensus price target of 2.5 to the stock, which implies a rise of 43.6% to its current value. Analysts have been projecting 2.5 as a low price target for the stock while placing it at a high target of 2.5. It follows that stock’s current price would drop -77.3% in reaching the projected high whereas dropping to the targeted low would mean a loss of -77.3% for stock’s current value.
Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of -0.26% during past 5 years. In 2025, company’s earnings growth rate is likely to be around 11.46% while estimates for its earnings growth in next 5 years are of 27.89%.
Icecure Medical Ltd (NASDAQ:ICCM)’s Major holders
CITADEL ADVISORS LLC is the top institutional holder at ICCM for having 0.17 million shares of worth $0.13 million. And as of 2024-06-30, it was holding 0.3627 of the company’s outstanding shares.
The second largest institutional holder is RENAISSANCE TECHNOLOGIES LLC, which was holding about 66400.0 shares on 2024-06-30. The number of shares represents firm’s hold over 0.1421 of outstanding shares, having a total worth of $49136.0.
